SCHEMBL27630458

SCHEMBL27630458

NC(=O)c1cc(F)c(C=O)c(I)c1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ERN1 O75460 7/20 0.39
▸ BPTF Q12830 1/20 0.36
▸ PARP1 P09874 2/20 0.35
▸ PTPN11 Q06124 1/20 0.33
▸ CES2 O00748 2/20 0.32
▸ CES1 P23141 2/20 0.32
▸ PARP10 Q53GL7 1/20 0.32
▸ PARP3 Q9Y6F1 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ TPMT P51580 1/20 0.31
▸ HTR2A P28223 1/20 0.31
▸ HTR2C P28335 1/20 0.31
▸ KCNH2 Q12809 1/20 0.31
▸ VNN1 O95497 1/20 0.31
▸ HDAC1 Q13547 1/20 0.31
▸ HDAC6 Q9UBN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16042892 0.76 CA1 (0.47) ERN1BPTFPARP1PTPN11CES2
SCHEMBL3783315 0.74 PARP1 (0.43) ERN1BPTFPARP1PTPN11CES2
SCHEMBL1233573 0.74 HDAC1 (0.44) BPTFPARP1PTPN11CES2CES1
SCHEMBL15539961 0.69 PARP1 (0.53) ERN1PARP1CES2CES1PARP10
Formic Acid SCHEMBL30995347 0.69 ERN1 (0.50) ERN1PARP1PTPN11CES2CES1
SCHEMBL23890741 0.69 ERN1 (0.31) ERN1
SCHEMBL7161332 0.69 PARP1 (0.49) ERN1PARP1CES2CES1PARP10
SCHEMBL23534334 0.69 ERN1 (0.34) ERN1
SCHEMBL1799276 0.69 CES2 (0.64) ERN1PARP1PTPN11CES2CES1
SCHEMBL29375224 0.69 ERN1 (0.67) ERN1PTPN11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100341874-C Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof NOVARTIS AG (CH) 2007-10-10 — — CN disclosed
CN-1784404-A Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof NOVARTIS AG (CH) 2006-06-07 — — CN disclosed
Send feedback